{"id":259,"date":"2023-12-06T15:15:48","date_gmt":"2023-12-06T15:15:48","guid":{"rendered":"https:\/\/explore.terumoaortic.com\/neurological-events\/?page_id=259"},"modified":"2025-09-26T09:23:45","modified_gmt":"2025-09-26T08:23:45","slug":"home","status":"publish","type":"page","link":"https:\/\/explore.terumoaortic.com\/neurological-events\/","title":{"rendered":"Neurological Events"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Neurological Events<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Uniquely Inspired for Ideal Placement<\/h1>

Precision. Reliability. Outcomes.<\/span><\/em><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tExplore<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tWatch the Video<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Neurological\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Behind the Scenes of TEVAR:\nFrom Challenge...<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t

\n\t\t\t\tIntraoperative solid<\/strong> or gaseous emboli<\/strong> are considered among the most\ncommon etiologies for NBI 1<\/sup>\t\t\t<\/p>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\tKaraolanis et al. (2022)<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
NBI = Neurological Brain Injury<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Potential NBI Risk Factors<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Manipulation of Endovascular Instruments 1<\/sup><\/span><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Prothrombotic tendency of the wires and catheters 1<\/sup><\/span><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Deployment of large stent grafts in a diseased atherosclerotic aorta <\/span>1<\/sup><\/span><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CAN LEAD TO<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Dislodgement of: 1<\/sup><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tAtheromatous debris<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tArterial Wall<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tFresh and organised thrombous<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    The publication and data presented here are provided as a general overview of TEVAR and may not directly relate to the approved indications for RelayPro. Indications for use may vary by region. Always consult the Instructions for Use for relevant indications, contraindications, warnings, and precautions.<\/strong><\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Pooled prevalence of any stroke associated
    with the TEVAR procedure<\/b> 1<\/sup><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t<\/span>\n\t\t\t\t100<\/span>\n\t\t\t\t%<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    This meta-analysis included patients with a variety of thoracic aortic diseases treated with TEVAR, including Type B aortic dissection (37.5%), descending thoracic aortic aneurysm (33.6%), penetrating aortic ulcer (7.2%), pseudoaneurysm (6.1%), traumatic transection (5.3%), and other etiologies (10.3%) i.e., intramural hematoma, floating thrombus, septic conditions, endoleaks.<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    \u2026to Impact<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Short-term Impact 2<\/sup><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    \n\t\t\t\tThe development of perioperative stroke was associated with significantly higher: 2<\/sup>\t\t\t<\/p>\n\t\t\t\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t\t\tUllery et al. (2012)<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Comparison Between Patients With and Without Perioperative Stroke<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    In Hospital Mortality<\/span><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    20% (4\/20) vs. 6% (29\/510)<\/div>
    p=0.03<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Arrythmia<\/span><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    30% (6\/20) vs. 9% (47\/510)<\/div>
    p=0.01<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Cardiac Arrest<\/span><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    10% (2\/20) vs. 1% (5\/510)<\/div>
    p=0.03<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    In this retrospective review, indications for surgery among those patients developing perioperative stroke (3.8%, 20\/530) included degenerative aneurysm (n=14), acute type B dissection (n=4), penetrating atherosclerotic ulcer (n=1), and aortic transection (n=1). The publications and data presented here are provided as a general overview on TEVAR and may not directly relate to the RelayPro approved indications. Indications for use will also differ by region. Always consult the Instructions for Use for the relevant indications, contraindications, warnings and precautions.<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Long-term Impact 2<\/sup><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    \n\t\t\t\tPatients without perioperative stroke had significantly better survival outcomes than those with perioperative stroke (log-rank, P=.02) 2<\/sup>\t\t\t<\/p>\n\t\t\t\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t\t\tUllery et al. (2012)<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Kaplan-Meier survival outcomes for patients with and without perioperative strokes after thoracic endovascular repair (TEVAR)<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Stroke\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    In this retrospective review, indications for surgery among those patients developing perioperative stroke (3.8%, 20\/530) included degenerative aneurysm (n=14), acute type B dissection (n=4), penetrating atherosclerotic ulcer (n=1), and aortic transection (n=1). The publications and data presented here are provided as a general overview on TEVAR and may not directly relate to the RelayPro approved indications. Indications for use will also differ by region. Always consult the Instructions for Use for the relevant indications, contraindications, warnings and precautions.<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Discover the Truth,\nExperience the Difference: Relay\u00aePro\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Stroke Rate through 1-Year Follow-up<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t
    \n\t\t\t\n\t\t\t\t<\/tr><\/tbody>\n\t\t\t<\/table>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Definition of stroke may differ by publication\/study and may be differentiated by severity of outcome and\/or timing post-index procedure. Additional details are provided within the relevant publications and should be considered. Stroke was adjudicated by the Clinical Events Committee per the specific study definition for references 3, 4, 5, 6, and 7. For the Cook dissection study, reference 10 and the Cook Zenith TX2 IFU (2022-05, I-DISSECT-SYSTEM-441-02EN) were used as references.<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Stroke Rate through 1-Year Follow-up<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t
    \n\t\t\t
    <\/div><\/div><\/th>
    \"RelayPro\"

    Terumo Aortic<\/h4>

    Relay\u00aePro<\/h3><\/div><\/div><\/div><\/th>

    \"RelayPro\"

    Medtronic<\/h4>

    Valiant\u2122 Captivia\u2122<\/h3><\/div><\/div><\/div><\/th>

    \"TAG

    Gore<\/h4>

    TAG\u00ae Conformable<\/h3><\/div><\/div><\/div><\/th>

    \"RelayPro\"

    Cook<\/h4>

    Zenith\u00ae<\/h3><\/div><\/div><\/div><\/th><\/tr><\/thead>\n\t\t\t\t\t\t\t\t

    The data presented reflect cumulative results. Product images obtained from Medtronic, Gore and Cook, online. All rights belong to their respective owners.
    * Strokes which did not meet the study definition of disabling (a sudden, non-convulsive loss of neurological function due to an ischemic or haemorrhagic intracranial vascular event defined as focal neurological deficits that impair the subject\u2019s day-to-day life as assessed by the CEC members, lasting for 365 days or longer) had a rate of 5.4% (3\/56)
    ^ Gore IDE stroke rate data for the 1-year follow-up is not available. The only available stroke rate data for Aneurysm and PAU from the IDE study is at the 30-day follow-up, reporting a rate of 3% (2\/66). <\/strong>5<\/sup>
    ^^ Gore IDE stroke rate data for the 1-year follow-up is not available. The only available stroke rate data for Type- B Dissection from the IDE study is at the 30-day follow-up, reporting a rate of 18% (9\/50)<\/strong> 9<\/sup> <\/h6><\/div><\/div><\/div><\/th><\/tr><\/tfoot>\n\t\t\t\t\t\t\t\t

    Aneurysm\nand PAU<\/h3><\/div><\/div><\/div><\/td>

    \n

    3.6%<\/h2>\n

    (4\/110) 3<\/sup><\/h6>\n<\/div><\/div><\/div><\/td>
    \n

    6.5%<\/h2>\n

    (10\/154) 4<\/sup><\/h6>\n<\/div><\/div><\/div><\/td>
    \n

    NA^<\/h2>\n<\/div><\/div><\/div><\/td>

    \n

    5%<\/h2>\n

    Zenith\u00ae Alpha\u2122
    (5\/110) 6<\/sup><\/h6><\/div><\/div><\/div><\/td><\/tr>

    Acute, Complicated\nType-B Dissection<\/h3><\/div><\/div><\/div><\/td>

    \n

    1.8%*<\/h2>\n

    (1\/56) 7<\/sup><\/h6><\/div><\/div><\/div><\/td>
    \n

    6%<\/h2>\n

    (3\/50) 8<\/sup><\/h6><\/div><\/div><\/div><\/td>
    \n

    NA^^<\/h2>\n<\/div><\/div><\/div><\/td>

    \n

    8.2%<\/h2>\n

    Zenith\u00ae TX2\u00ae
    (6\/73) 10<\/sup><\/h6><\/div><\/div><\/div><\/td><\/tr>
    \n\t\t\t\t<\/tr><\/tbody>\n\t\t\t<\/table>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t
    \n\t\t\t
    \"RelayPro\"

    Terumo Aortic<\/h4>

    Relay\u00aePro<\/h3><\/div><\/div><\/div><\/th><\/tr><\/thead>\n\t\t\t\t\t\t\t\t

    \n

    Aneurysm and PAU<\/h3>

    3.6%<\/h2>\n

    (4\/110) 3<\/sup><\/h6>\n<\/div><\/div><\/div><\/td><\/tr>
    \n

    Acute, Complicated
    Type-B Dissection<\/h3>

    1.8%*<\/h2>\n

    (1\/56) 7<\/sup><\/h6><\/div><\/div><\/div><\/td><\/tr>
    \n\t\t\t\t<\/tr><\/tbody>\n\t\t\t<\/table>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t
    \n\t\t\t
    \"RelayPro\"

    Medtronic<\/h4>

    Valiant\u2122 Captivia\u2122<\/h3><\/div><\/div><\/div><\/th><\/tr><\/thead>\n\t\t\t\t\t\t\t\t

    \n

    Aneurysm and PAU<\/h3>

    6.5%<\/h2>\n

    (10\/154) 4<\/sup><\/h6>\n<\/div><\/div><\/div><\/td><\/tr>

    Acute, Complicated
    Type-B Dissection<\/h3>

    6%<\/h2>\n

    (3\/50) 8<\/sup><\/h6><\/div><\/div><\/div><\/td><\/tr>
    \n\t\t\t\t<\/tr><\/tbody>\n\t\t\t<\/table>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t
    \n\t\t\t
    \"TAG

    Gore<\/h4>

    TAG\u00ae Conformable<\/h3><\/div><\/div><\/div><\/th><\/tr><\/thead>\n\t\t\t\t\t\t\t\t

    \n

    Aneurysm and PAU<\/h3>

    NA^<\/h2>\n<\/div><\/div><\/div><\/td><\/tr>

    \n

    Acute, Complicated
    Type-B Dissection<\/h3>

    NA^^<\/h2>\n<\/div><\/div><\/div><\/td><\/tr>

    \n\t\t\t\t<\/tr><\/tbody>\n\t\t\t<\/table>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    The data presented reflect cumulative results. Product images obtained from Medtronic, Gore and Cook, online. All rights belong to their respective owners.
    * Strokes which did not meet the study definition of disabling (a sudden, non-convulsive loss of neurological function due to an ischemic or haemorrhagic intracranial vascular event defined as focal neurological deficits that impair the subject\u2019s day-to-day life as assessed by the CEC members, lasting for 365 days or longer) had a rate of 5.4% (3\/56)
    ^ Gore IDE stroke rate data for the 1-year follow-up is not available. The only available stroke rate data for Aneurysm and PAU from the IDE study is at the 30-day follow-up, reporting a rate of 3% (2\/66). <\/strong>5<\/sup>
    ^^ Gore IDE stroke rate data for the 1-year follow-up is not available. The only available stroke rate data for Type- B Dissection from the IDE study is at the 30-day follow-up, reporting a rate of 18% (9\/50)<\/strong> 9<\/sup><\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    Definition of stroke may differ by publication\/study and may be differentiated by severity of outcome and\/or timing post-index procedure. Additional details are provided within the relevant publications and should be considered. Stroke was adjudicated by the Clinical Events Committee per the specific study definition for references 3, 4, 5, 6, and 7. For the Cook dissection study, reference 10 and the Cook Zenith TX2 IFU (2022-05, I-DISSECT-SYSTEM-441-02EN) were used as references.<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Relay\u00aePro Key Features\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"low\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Low Profile Delivery System<\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"dual\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Dual Sheath Technology<\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"pre\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Pre-curved Nitinol Inner Catheter<\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    \n\t\t\t\t\u2026Low-Profile stent-grafts [LPSG**] might contribute to reducing embolization by less friction to the\naortic wall during TEVAR compared with Conventional-sized stent-graft [CSSG] 11<\/sup>\t\t\t<\/p>\n\t\t\t\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t\t\tSeike et al. (2023)<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    ** Includes RelayPro and Cook Zenith Alpha<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    \n\t\t\t\t...one stable outer sheath for support during advancement and a second inner, flexible sheath which\nallows atraumatic navigation to and across the aortic arch 12<\/sup>\t\t\t<\/p>\n\t\t\t\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t\t\tEl Beyrouti et al. (2020)<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    The RelayPro delivery system design is independent of indication. The RelayPro is NOT indicated for erosion, rupture and the FDA-approved device is also NOT indicated for IMH and is only intended for the DTA. Approved indications will vary by region, always consult the corresponding IFU<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    \n\t\t\t\t...some devices were designed to reduce friction at the aortic arch by adding a curve to the\ndevice sheath 11<\/sup>\t\t\t<\/p>\n\t\t\t\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t\t\tSeike et al. (2023)<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Watch the Video<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    \n
    \n

    \"RelayPro\"

    Cook<\/h4>

    Zenith\u00ae<\/h3><\/div><\/div><\/div><\/th><\/tr><\/thead>\n\t\t\t\t\t\t\t\t

    Aneurysm and PAU<\/h3>

    5%<\/h2>\n

    Zenith\u00ae Alpha\u2122
    (5\/110) 6<\/sup><\/h6><\/div><\/div><\/div><\/td><\/tr>

    Acute, Complicated
    Type-B Dissection<\/h3>

    8.2%<\/h2>\n

    Zenith\u00ae TX2\u00ae
    (6\/73) 10<\/sup><\/h6><\/div><\/div><\/div><\/td><\/tr>